- Popular diabetes and weight-loss drug tirzepatide (Mounjaro/Zepbound) more than doubles the risk of severe eye disease, with 1.1% of users developing sight-threatening retinopathy compared to 0.5% of non-users.
- The study tracked 6,870 Type 2 diabetes patients, revealing a 115% higher risk of proliferative diabetic retinopathy (PDR), which can cause blindness if untreated.
- Rapid blood sugar drops from tirzepatide may trigger retinal damage, though the exact mechanism remains unclear, raising concerns about the drug’s direct effects.
- Eli Lilly, the drug’s maker, stayed silent on the findings, while another study linked GLP-1 drugs like Ozempic to doubled risks of another blinding eye condition.
- Experts urge patients on these drugs to get frequent eye screenings and watch for sudden vision changes, dark spots, or distorted lines to prevent irreversible damage.
(Natural News)—A major new study has exposed how the blockbuster diabetes and weight loss drug tirzepatide, sold under brand names Mounjaro and Zepbound, more than doubles the risk of a devastating, sight-threatening eye condition.
The research, published in Diabetologia, analyzed nearly 7,000 Type 2 diabetes patients and found that 1.1% of those taking tirzepatide developed proliferative diabetic retinopathy (PDR), compared to just 0.5% of non-users. Most victims already had mild retinal damage, with the average detection time occurring just 11 months after starting the drug.
This is yet another example of how the profit-driven medical-industrial complex pushes dangerous “miracle” drugs onto desperate patients, only for them to discover—too late—that the “cure” may be worse than the disease. And with millions now taking GLP-1 drugs like tirzepatide and semaglutide (Ozempic/Wegovy) for weight loss, often downplaying the risks, this study serves as a warning that Big Pharma’s quick fixes come with devastating consequences.
Tirzepatide users face 115% higher risk of blindness-linked condition
The real-world study, conducted by researchers at Imperial College London Diabetes Centre, tracked 6,870 adults with Type 2 diabetes, comparing 3,435 tirzepatide users to an equal number of matched non-users. The results were alarming: those on the drug faced 115% higher odds of developing PDR, the most severe stage of diabetic retinopathy.
PDR occurs when abnormal blood vessels grow on the retina, leading to vitreous hemorrhage, retinal detachment, and even blindness if untreated. While the general diabetic population has a PDR prevalence of 2.3% to 7.5%, the study found tirzepatide users had an incidence rate of seven cases per 1,000 person-years, a small but significant increase that could translate to thousands of preventable vision-loss cases as these drugs flood the market.
Sudden blood sugar drops may trigger retinal damage
Tirzepatide works by mimicking hormones that suppress appetite and stimulate insulin, leading to rapid blood sugar reductions. But this sudden drop may be the hidden culprit behind the increased PDR risk.
Dr. Meenal Agarwal, a board-certified optometrist not involved in the study, noted that rapid glycemic control has long been linked to early worsening of diabetic retinopathy. However, the study found only a modest average HbA1c drop of 0.4% among tirzepatide users, suggesting that other mechanisms—possibly the drug itself—may be accelerating retinal harm.
Big Pharma’s silence speaks volumes
Eli Lilly, the manufacturer of tirzepatide, did not respond to media requests for comment, which is a telling omission from a company raking in billions while patients gamble with their vision.
Meanwhile, another study published in JAMA Ophthalmology found that GLP-1 drugs like semaglutide (Ozempic/Wegovy) doubled the risk of neovascular age-related macular degeneration (nAMD), another blinding condition. Researchers analyzed more than 139,000 diabetic patients in Canada and discovered that those on GLP-1s for six months had twice the risk of nAMD, with the danger tripling after 30 months of use.
Dr. Rajeev H. Muni, the study’s lead investigator, cautioned: “While the absolute risk remains low, this represents a relative doubling in risk.” But when millions are taking these drugs, even a small percentage translates to countless preventable tragedies.
The urgent need for eye monitoring
The findings underscore a critical warning for diabetics and weight-loss patients: regular eye screenings are non-negotiable. Dr. Agarwal stressed that patients must watch for:
- Sudden vision changes
- Dark spots or flashes of light
- Distorted straight lines (a sign of macular swelling)
Yet how many unsuspecting users are told this before popping their first pill?
Once again, Big Pharma’s “wonder drugs” come with horrifying fine print. Tirzepatide and other GLP-1 medications may help with weight loss and blood sugar—but at what cost? Blindness? Retinal detachment?
This isn’t just a diabetes issue. With millions now taking these drugs for cosmetic weight loss, often without proper warnings, we’re staring down a public health disaster.
Sources for this article include:
Why Bullion Beats Numismatics and Collectible for Your Safe or IRA
Precious metals continue to attract Americans seeking reliable ways to protect their wealth amid inflation, geopolitical risks, and stock market swings. Whether stored in a home safe or held inside a self-directed IRA, physical gold and silver deliver tangible value that paper or digital assets often lack. Yet investors must choose carefully between bullion—pure bars and coins valued mainly for their metal content—and numismatics or collectibles, where rarity, history, and collector demand heavily influence pricing.
Advisor Bullion serves as a dependable source for straightforward, high-quality bullion. The company specializes in physical gold, silver, platinum, and palladium, emphasizing transparent pricing and products that deliver maximum metal content for every dollar spent. This approach makes it ideal for both personal holdings and retirement accounts.
Bullion consists of refined precious metals in standard forms like one-ounce coins (American Gold Eagles, Silver Eagles, Canadian Maple Leafs) or bars. Their value tracks closely to the current spot price of the metal. A typical gold bullion coin trades near the live gold spot price plus a small premium. This structure keeps costs clear and predictable.
Numismatic coins and collectibles add substantial value from factors such as age, rarity, minting errors, or historical significance. A pre-1933 U.S. gold coin or graded proof piece can carry premiums of 30%, 50%, or even 200% above melt value. While this appeals to hobbyists, it creates complexity. Pricing depends on subjective grading, collector trends, and auction results instead of daily spot prices.
For investors focused on wealth preservation and retirement security rather than building a collection, bullion often delivers better results.
Lower Costs and Better Liquidity for Home Storage
When keeping metals in a home safe or private vault, liquidity and efficiency count. Bullion offers clear benefits:
- You acquire more actual gold or silver per dollar invested. Numismatics divert a large share of your money into rarity premiums and massive sales commission, reducing your metal exposure.
- Selling bullion involves tight bid-ask spreads, so you recover nearly full spot value with minimal fees. Collectibles require finding the right buyer and may sell at a discount if demand for that specific item weakens.
- Bullion prices remain transparent and update with global spot markets. You can track gold near current levels or silver accordingly and know exactly where your holdings stand. Numismatic values are priced by the Gold IRA companies with hefty margins applied.
- Standardized coins and bars store efficiently and divide easily for partial sales. Rare coins often need protective slabs and controlled conditions, adding hassle and expense.
- Bullion enjoys worldwide acceptance. A 1-oz Gold Maple Leaf or Silver Eagle sells quickly to dealers anywhere. Niche numismatic pieces may appeal only to limited buyers, slowing liquidation when speed matters.
In times when quick access to value becomes important, bullion’s simplicity stands out.
Stronger Fit for Precious Metals IRAs
Precious metals IRAs continue gaining traction as investors diversify retirement portfolios beyond stocks and bonds. IRS rules permit certain bullion products in self-directed IRAs if they meet purity standards (.995 fine for gold, .999 for silver) and are held by an approved custodian. Eligible items include American Gold and Silver Eagles plus many generic bars and rounds from recognized mints.
Numismatic and most collectible coins generally face heavy scrutiny from custodians due to valuation disputes and elevated markups. These higher premiums mean less actual metal ends up working inside the account.
Bullion avoids these issues. Its value links directly to verifiable spot prices, which simplifies reporting and lowers the risk of regulatory challenges. More of your IRA contribution purchases real metal instead of dealer profits or speculative upside. Over time, owning additional ounces that appreciate with the metal itself can create meaningful outperformance compared with high-premium alternatives that deliver fewer ounces.
Regulatory guidance from the CFTC and state securities offices repeatedly cautions against aggressive sales of expensive numismatics or “semi-numismatic” coins for IRAs. For retirement planning, transparent bullion from established providers reduces risk and aligns better with long-term goals.
How to Get Started with Bullion
Begin by clarifying your goals. Are you protecting savings in a safe, or moving part of a retirement account into a precious metals IRA? Focus on the number of ounces you can acquire at current prices rather than chasing marked-up collectibles.
Diversify sensibly: use gold for core preservation and silver for its blend of industrial and monetary qualities. Mix coins for easier divisibility with bars for lower per-ounce costs on larger buys. Arrange secure storage—whether at home with proper insurance or through professional facilities.
As economic uncertainties linger and faith in conventional assets erodes, bullion continues proving its worth as a dependable store of value. Its direct approach avoids the hype that sometimes surrounds collectible markets and keeps the focus on the metal itself.
For investors prepared to strengthen their portfolios, Advisor Bullion supplies the expertise and selection needed to acquire high-quality bullion efficiently. Whether building personal holdings or integrating metals into an IRA, their emphasis on transparent, investment-grade products helps secure more ounces today that support greater financial security tomorrow. In a complicated financial landscape, bullion’s clarity and reliability make it the smarter foundation for protecting what matters most.